Profile data is unavailable for this security.
About the company
Cisen Pharmaceutical Co., Ltd is a China-based company principally involved in the research, development, manufacturing and sales of medical products. The Company operates through two main segments. The Main Business segment is primarily involved in the manufacturing and sales of medicine, among which include infusion, freeze-dried powder, small volume injection, tablet, capsules, ointment, drops and active pharmaceutical ingredients, among others. The Other Business segment is mainly involved in the sales of raw materials and houses tenancy.
- Revenue in CNY (TTM)4.48bn
- Net income in CNY528.35m
- Incorporated1998
- Employees3.40k
- LocationCisen Pharmaceutical Co LtdNo.16 Tongji Road, Hi-tech ZoneJINING 272073ChinaCHN
- Phone+86 5 372989906
- Fax+86 5 372215851
- Websitehttp://www.cisen-pharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chengdu Easton Biopharmaceuticals Co Ltd | 1.15bn | 240.60m | 6.17bn | 1.40k | 25.54 | 2.33 | -- | 5.34 | 2.01 | 2.01 | 9.65 | 22.07 | 0.3566 | 1.54 | 7.73 | 824,469.80 | 7.43 | 8.72 | 9.15 | 10.64 | 77.92 | 85.10 | 20.84 | 19.16 | 2.59 | -- | 0.0861 | 26.80 | -4.56 | 7.76 | -8.09 | 10.91 | 17.99 | -- |
| Shandong Lukang Pharmaceutical Co Ltd | 6.28bn | 267.79m | 6.23bn | 6.48k | 23.76 | 1.69 | -- | 0.9921 | 0.292 | 0.292 | 6.88 | 4.11 | 0.7187 | 3.54 | 6.45 | 967,865.70 | 3.21 | 2.21 | 5.51 | 4.05 | 23.55 | 23.41 | 4.47 | 3.46 | 0.7313 | 5.39 | 0.4689 | 31.79 | 9.34 | 13.04 | 78.37 | 8.81 | -16.95 | 23.94 |
| JiangSu WuZhong Pharmactcl Devlpm Co Ltd | 2.33bn | -95.04m | 6.43bn | 1.05k | -- | 3.63 | -- | 2.76 | -0.1335 | -0.1335 | 3.22 | 2.48 | 0.553 | 16.07 | 2.29 | 2,220,525.00 | -2.31 | -2.92 | -4.78 | -5.30 | 22.41 | 28.14 | -4.18 | -5.77 | 1.22 | -0.3232 | 0.5063 | -- | 10.55 | 5.65 | 5.58 | -- | -19.08 | -- |
| Cisen Pharmaceutical Co Ltd | 4.48bn | 528.35m | 6.46bn | 3.40k | 12.26 | 1.10 | -- | 1.44 | 1.16 | 1.16 | 9.86 | 13.02 | 0.6082 | 2.81 | 5.65 | 1,315,959.00 | 7.21 | 6.94 | 9.02 | 8.56 | 57.33 | 56.27 | 11.85 | 10.77 | 3.12 | -- | 0.0373 | 33.42 | 9.75 | 3.22 | 48.92 | 0.697 | -15.19 | 10.72 |
| Beijing Foyou Pharma Co Ltd | 3.32bn | 507.64m | 6.58bn | 3.44k | 12.91 | 1.87 | -- | 1.98 | 1.06 | 1.06 | 6.95 | 7.35 | 0.7482 | 3.46 | 9.58 | 967,165.90 | 11.50 | -- | 14.81 | -- | 65.14 | -- | 15.37 | -- | 2.99 | -- | 0.0316 | -- | 3.07 | -- | 11.36 | -- | -- | -- |
| Harbin Pharmaceutical Group Co., Ltd. | 15.67bn | 449.71m | 6.63bn | 9.85k | 14.39 | 1.35 | -- | 0.4232 | 0.1827 | 0.1827 | 6.34 | 1.95 | 1.13 | 6.35 | 3.46 | 1,590,093.00 | 3.79 | 0.7414 | 10.20 | 1.89 | 26.30 | 23.87 | 3.35 | 0.7294 | 1.06 | 40.41 | 0.393 | 0.00 | 11.93 | 7.41 | -14.88 | 2.69 | -5.38 | -- |
| Shouyao Holdings Co Ltd | 5.23m | -191.79m | 6.67bn | 185.00 | -- | 6.89 | -- | 1,274.99 | -1.29 | -1.29 | 0.0352 | 6.51 | 0.0045 | 0.2644 | 5.25 | 28,265.68 | -16.55 | -37.24 | -18.01 | -42.63 | 96.50 | 96.03 | -3,667.74 | -2,251.77 | 8.49 | -- | 0.0018 | -- | 186.18 | -23.51 | -6.76 | -- | 34.59 | -- |
Data as of Jun 25 2024. Currency figures normalised to Cisen Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
1.40%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| ABC-CA Fund Management Co., Ltd.as of 31 Dec 2023 | 1.60m | 0.36% |
| Great Wall Fund Management Co., Ltd.as of 31 Dec 2023 | 900.00k | 0.20% |
| Dimensional Fund Advisors LPas of 06 Jun 2024 | 690.80k | 0.15% |
| Bank of China Investment Management Co., Ltd.as of 31 Dec 2023 | 637.50k | 0.14% |
| Penghua Fund Management Co., Ltd.as of 31 Dec 2023 | 551.50k | 0.12% |
| Essence Fund Co., Ltd.as of 31 Dec 2023 | 517.80k | 0.12% |
| Orient Securities Asset Management Co. Ltd.as of 31 Dec 2023 | 455.80k | 0.10% |
| Zhong Ou Asset Management Co., Ltdas of 31 Dec 2023 | 369.80k | 0.08% |
| UBS SDIC Fund Management Co., Ltd.as of 30 Jun 2023 | 311.90k | 0.07% |
| ICBC Credit Suisse Asset Management Co., Ltd.as of 31 Dec 2023 | 292.60k | 0.07% |
More ▼
Data from 30 Jun 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
